AAAAAA

   
Results: 1-8 |
Results: 8
Treatment planning aids in prostate cancer: Friend or foe?
Authors: Malone, S Donker, R Dahrouge, S Eapen, L Aref, I Perry, G Szanto, J
Citation: S. Malone et al., Treatment planning aids in prostate cancer: Friend or foe?, INT J RAD O, 51(1), 2001, pp. 49-55
A prospective comparison of three systems of patient immobilization for prostate radiotherapy
Authors: Malone, S Szanto, J Perry, G Gerig, L Manion, S Dahrouge, S Crook, J
Citation: S. Malone et al., A prospective comparison of three systems of patient immobilization for prostate radiotherapy, INT J RAD O, 48(3), 2000, pp. 657-665
Respiratory-induced prostate motion: Quantification and characterization
Authors: Malone, S Crook, JM Kendal, WS Szanto, J
Citation: S. Malone et al., Respiratory-induced prostate motion: Quantification and characterization, INT J RAD O, 48(1), 2000, pp. 105-109
Effects of urethrography on prostate position: Considerations for radiotherapy treatment planning of prostate carcinoma
Authors: Malone, S Donker, R Broader, M Dahrouge, S Szanto, J Gerig, L Bociek, G Crook, J
Citation: S. Malone et al., Effects of urethrography on prostate position: Considerations for radiotherapy treatment planning of prostate carcinoma, INT J RAD O, 46(1), 2000, pp. 89-93
Severe normal tissue complication correlates with increased in vitro fibroblast radiosensitivity in radical prostate radiotherapy: A case report
Authors: Raaphorst, GP Malone, S Szanto, J Gray, R
Citation: Gp. Raaphorst et al., Severe normal tissue complication correlates with increased in vitro fibroblast radiosensitivity in radical prostate radiotherapy: A case report, INT J CANC, 90(6), 2000, pp. 336-342
The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma
Authors: Papai, Z Bodoky, G Szanto, J Poller, I Rahoty, P Eckhardt, S Lang, I Szendroi, M
Citation: Z. Papai et al., The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma, CANCER, 89(1), 2000, pp. 177-180
Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial
Authors: Kloke, O Klaassen, U Oberhoff, C Hartwich, G Szanto, J Wolf, E Heckmann, M Huhn, R Stephan, L Schnepper, U Donsbach, GM Bechtel, C Rudolph, R Berke, A Borquez, D Hawig, I Hirche, H Schindler, AE Seeber, S Becher, R
Citation: O. Kloke et al., Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial, BREAST CANC, 55(1), 1999, pp. 51-59
Changes in apoptotic and mitotic activity in rectal carcinoma after short-term cytostatic therapy as possible predictive factors
Authors: Farczadi, E Szanto, J Kaszas, I Benyo, I Bodnar, Z Szlobodnyik, J Szende, B
Citation: E. Farczadi et al., Changes in apoptotic and mitotic activity in rectal carcinoma after short-term cytostatic therapy as possible predictive factors, NEOPLASMA, 46(4), 1999, pp. 219-223
Risultati: 1-8 |